DESCRIPTION

A long-lasting solution to collagen deficiency-related facial volume loss is provided by Ellanse S. The natural response of the body, specifically the production of collagène, is what this product uses to excite the skin. Products from Ellansé (Ellansé, S & M, respectively) promise results that are both perceptible and durable for one to two years. Within the subcutanous layer (hypoderme and sus-perioste), is the Ellansé injection zone.

The main component of Ellansé is synthetic poly-caprolactone (PCL) microspheres suspended in a carrier gel comprised of tampon phosphate salin (Ph. Eur. ), glycérine (Ph. Eur.), and carboxymethylcellubse (USP). Ellansé is a non-permanent, sterile, latex-free, entirely resorbable implant. A well-known, fully biodegradable medicinal therapeutic polymer is called PCL. The Food and Drug Administration (FDA) has certified PCL for use in numerous commercially available absorbable goods carrying the CE mark for many years, and this has demonstrated PCL’s excellent safety profile. ELLANSÉ requires the use of a 27G needle for injection, and the particle size ranges from 25 to 50 microns.

Sinclair Ellanse S – Ingredients: Products containing Ellanse (S & M) are created of 70 percent carb oxymethylcellulose (CMC). The gel vector, or CMC, delivers an instant volumizing effect.
30% of the material is polycaprolactone (PCL) in the form of spheres (25–50 nm). To produce a sustained volumizing effect, PCL microspheres replace CMC gel.
The biodegradability, biocompatibility, and bioresorbability of these two substances are all complete.

Ellansé is totally hydrolyzable and resorbable.

It should be noted that Ellansé S and Ellansé M have different polycaprolactone chain lengths, which causes a slower or quicker rate of absorption (1 to 2 years, respectively).

Qualified professionals must handle this product.